$0.410
+0 (+0%)
At Close: Mar 13, 2026
Clearside Biomedical Inc (CLSD) CEO George Lasezkay on Q2 2022 Results - Earnings Call Transcript
02:47pm, Tuesday, 09'th Aug 2022
Clearside Biomedical Inc (NASDAQ:CLSD ) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Jenny Kobin - Head of IR George Lasezkay - President, CEO and Director Tom Ciull
Clearside Biomedical to Participate in Three Upcoming Investor Conferences in August 2022
07:05am, Wednesday, 03'rd Aug 2022
ALPHARETTA, Ga., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the s
Clearside Biomedical to Report Second Quarter 2022 Financial Results and Provide Corporate Update on Tuesday, August 9, 2022
07:05am, Wednesday, 27'th Jul 2022
ALPHARETTA, Ga., July 27, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the s
Clearside Biomedical, Inc.'s (CLSD) CEO George Lasezkay on Q1 2022 Results - Earnings Call Transcript
09:11pm, Wednesday, 11'th May 2022
Clearside Biomedical, Inc. (NASDAQ:CLSD ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Jenny Kobin - Investor Relations George Lasezkay - President and Chief Executive
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates
06:49pm, Wednesday, 11'th May 2022
Clearside Biomedical, Inc. (CLSD) delivered earnings and revenue surprises of -333.33% and 96.17%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the
Clearside Biomedical to Report First Quarter 2022 Financial Results and Provide Corporate Update on Wednesday, May 11, 2022
07:05am, Friday, 29'th Apr 2022
ALPHARETTA, Ga., April 29, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the
Clearside Biomedical: A Pivotal 2022 Ahead
06:19am, Wednesday, 13'th Apr 2022
XIPERE was officially launched by partner Bausch + Lomb in Q1 2022. CLS-AX cohort 3 has fully enrolled with a fourth cohort to be enrolled Q2 2022 pending safety review of cohort 3.
Clearside Biomedical to Present at the Needham Virtual Healthcare Conference
07:05am, Wednesday, 06'th Apr 2022
ALPHARETTA, Ga., April 06, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the
Clearside Stock Is up Over 80% In Three Trading Days. How Much Higher Can It Go?
10:38pm, Tuesday, 15'th Mar 2022 TipRanksCan you feel the ground moving beneath your feet? Shares of eye disease-focused Clearside Biomedical (CLSD) skyrocketed 84% over the past 3 trading sessions, after …
Good Trending Penny Stocks to Buy Now? Check These 3 Out
06:09pm, Monday, 14'th Mar 2022
Check these trending penny stocks out for your watchlist The post Good Trending Penny Stocks to Buy Now? Check These 3 Out appeared first on Penny Stocks to Buy, Picks, News and Information | PennyS
95 Biggest Movers From Friday
08:52am, Monday, 14'th Mar 2022 Benzinga
Gainers Marygold Companies (NYSE: MGLD ) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday. TeraWulf Inc. (NASDAQ: WULF ) gained 49.3% to close at $9.51. Guardforce AI Co., Limited (NASDAQ: GFAI ) jumped 45% to settle at $0.7796 after the company agreed to acquire Shenzhen Keweien and Guangzhou Kewei for $10 million. Clearside Biomedical, Inc. (NASDAQ: CLSD ) rose 42.6% to settle at $1.9250 after the company reported better-than-expected Q4 results. Excellon Resources Inc. (NYSE: EXN ) rose 40.8% to close at $1.38 after jumping around 13% on Thursday. Solid Biosciences Inc. (NASDAQ: SLDB ) jumped 37.4% to settle at $1.06. Altamira Therapeutics Ltd. (NASDAQ: CYTO ) shares gained 36.7% to settle at $0.9449. Altamira Therapeutics reported in vitro efficacy data for bentrio nasal spray in protecting against Sars-CoV-2 omicron variant. 4D pharma plc (NASDAQ: LBPS ) shares surged 35.3% to settle at $3.99. Kala Pharmaceuticals, Inc. (NASDAQ: KALA ) gained 33.1% to close at $1.69.
Mid-Afternoon Market Update: Nasdaq Falls 150 Points; Orphazyme Shares Plunge
07:38pm, Friday, 11'th Mar 2022 Benzinga
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq dropping 150 points on Friday. The Dow traded up 0.07% to 33,198.82 while the NASDAQ fell 1.18% to 12,975.53. The S&P also fell, dropping, 0.39% to 4,242.84. Check out this: Insiders Buy Around $98M Of 3 Stocks Leading and Lagging Sectors Financials shares climbed by 0.3% on Friday. Meanwhile, top gainers in the sector included Vinci Partners Investments Ltd. (NASDAQ: VINP ), up 5% and OppFi Inc. (NYSE: OPFI ) up 10%. In trading on Friday, communication services shares fell by 0.8%. Top Headline The Buckle, Inc. (NYSE: BKE ) reported better-than-expected results for its fourth quarter on Friday. Buckle reported Q4 earnings of $1.69 per share, beating analysts’ estimates of $1.44 per share. The company’s quarterly sales came in at $380.93 million, versus expectations of $366.30 million. Equities Trading UP Clearside Biomedical, Inc. (NASDAQ: CLSD ) shares shot up 32% to $1.7850 after the company reported better-than-expected Q4 results.
Mid-Day Market Update: Gold Down 1%; Clearside Biomedical Shares Jump
05:30pm, Friday, 11'th Mar 2022 Benzinga
U.S. stocks traded mixed midway through trading, with the Nasdaq dropping around 100 points on Friday. The Dow traded up 0.49% to 33,336.14 while the NASDAQ fell 0.73% to 13,032.47. The S&P also fell, dropping, 0.05% to 4,257.50. Check out this: Insiders Buy Around $98M Of 3 Stocks Leading and Lagging Sectors Financials shares climbed by 0.6% on Friday. Meanwhile, top gainers in the sector included Puyi Inc. (NASDAQ: PUYI ), up 8% and OppFi Inc. (NYSE: OPFI ) up 13%. In trading on Friday, energy shares fell by 0.5%. Top Headline The Buckle, Inc. (NYSE: BKE ) reported better-than-expected results for its fourth quarter on Friday. Buckle reported Q4 earnings of $1.69 per share, beating analysts’ estimates of $1.44 per share. The company’s quarterly sales came in at $380.93 million, versus expectations of $366.30 million. Equities Trading UP Clearside Biomedical, Inc. (NASDAQ: CLSD ) shares shot up 30% to $1.75 after the company reported better-than-expected Q4 results. Shares of Lazydays Holdings, Inc. (NASDAQ: LAZY ) got a boost, shooting 26% to $22.46 after the company reported Q4 earnings …
50 Stocks Moving In Friday''s Mid-Day Session
05:05pm, Friday, 11'th Mar 2022 Benzinga
Gainers Marygold Companies (NYSE: MGLD ) jumped 189.4% to $6.28 after dropping 21% on Thursday. Altamira Therapeutics Ltd. (NASDAQ: CYTO ) shares rose 63.5% to $1.13. Altamira Therapeutics reported in vitro efficacy data for bentrio nasal spray in protecting against Sars-CoV-2 omicron variant. Excellon Resources Inc. (NYSE: EXN ) rose 40.7% to $1.38 after jumping around 13% on Thursday. Clearside Biomedical, Inc. (NASDAQ: CLSD ) rose 35.5% to $1.8301 after the company reported better-than-expected Q4 results. Alset EHome International Inc. (NASDAQ: AEI ) shares rose 31% to $ 0.4555 after dropping 7% on Thursday. Humanigen, Inc. (NASDAQ: HGEN ) jumped 22.7% to $3.44. Lazydays Holdings, Inc. (NASDAQ: LAZY ) gained 22% to $21.80 after the company reported Q4 earnings results. Blue Star Foods Corp. (NASDAQ: BSFC ) jumped 19.8% to $2.54. 4D pharma plc (NASDAQ: LBPS ) shares climbed 19.7% to $3.53. Paramount Gold Nevada Corp. (NYSE: PZG ) rose 19% to $0.9404 after jumping 14% on Thursday. Pearson plc (NYSE: PSO ) gained 19% to $10.35.
Why Clearside Biomedical Shares Are Surging Today
04:22pm, Friday, 11'th Mar 2022 Benzinga
Clearside Biomedical Inc (NASDAQ: CLSD ) shares are trading higher Friday after the company reported better-than-expected fourth-quarter financial results. Clearside reported quarterly revenue of $25.69 million, which beat the $17.77 million estimate. Clearside said it earned 31 … Full story available on Benzinga.com
Sign In
Buy CLSD